These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25414155)

  • 1. Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
    Lovshin JA; Barnie A; DeAlmeida A; Logan A; Zinman B; Drucker DJ
    Diabetes Care; 2015 Jan; 38(1):132-9. PubMed ID: 25414155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial.
    Skov J; Pedersen M; Holst JJ; Madsen B; Goetze JP; Rittig S; Jonassen T; Frøkiaer J; Dejgaard A; Christiansen JS
    Diabetes Obes Metab; 2016 Jun; 18(6):581-9. PubMed ID: 26910107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.
    Kumarathurai P; Anholm C; Fabricius-Bjerre A; Nielsen OW; Kristiansen O; Madsbad S; Haugaard SB; Sajadieh A
    J Hypertens; 2017 May; 35(5):1070-1078. PubMed ID: 28129251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.
    Kim M; Platt MJ; Shibasaki T; Quaggin SE; Backx PH; Seino S; Simpson JA; Drucker DJ
    Nat Med; 2013 May; 19(5):567-75. PubMed ID: 23542788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
    Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
    Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients.
    Li CJ; Yu Q; Yu P; Yu TL; Zhang QM; Lu S; Yu DM
    Cardiovasc Diabetol; 2014 Feb; 13():36. PubMed ID: 24498905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Liakos A; Lambadiari V; Bargiota A; Kitsios K; Avramidis I; Kotsa K; Gerou S; Boura P; Tentolouris N; Dimitriadis G; Tsapas A
    Diabetes Obes Metab; 2019 Mar; 21(3):517-524. PubMed ID: 30242948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension.
    Wang TD; Tan RS; Lee HY; Ihm SH; Rhee MY; Tomlinson B; Pal P; Yang F; Hirschhorn E; Prescott MF; Hinder M; Langenickel TH
    Hypertension; 2017 Jan; 69(1):32-41. PubMed ID: 27849566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function.
    Wajdlich M; Nowicki M
    Sci Rep; 2024 Feb; 14(1):5002. PubMed ID: 38424466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes.
    Nielsen R; Jorsal A; Tougaard RS; Rasmussen JJ; Schou M; Videbaek L; Gustafsson I; Faber J; Flyvbjerg A; Wiggers H; Tarnow L; Kistorp C
    Diabetes Obes Metab; 2020 Nov; 22(11):2141-2150. PubMed ID: 32627271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.
    von Scholten BJ; Lajer M; Goetze JP; Persson F; Rossing P
    Diabet Med; 2015 Mar; 32(3):343-52. PubMed ID: 25251901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.
    Farr OM; Sofopoulos M; Tsoukas MA; Dincer F; Thakkar B; Sahin-Efe A; Filippaios A; Bowers J; Srnka A; Gavrieli A; Ko BJ; Liakou C; Kanyuch N; Tseleni-Balafouta S; Mantzoros CS
    Diabetologia; 2016 May; 59(5):954-65. PubMed ID: 26831302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
    Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus.
    Tanaka H; Takano K; Iijima H; Kubo H; Maruyama N; Hashimoto T; Arakawa K; Togo M; Inagaki N; Kaku K
    Adv Ther; 2017 Feb; 34(2):436-451. PubMed ID: 27981497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients.
    Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; van Raalte DH
    Diabetes Res Clin Pract; 2017 Feb; 124():1-10. PubMed ID: 28086201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
    Kumarathurai P; Anholm C; Larsen BS; Olsen RH; Madsbad S; Kristiansen O; Nielsen OW; Haugaard SB; Sajadieh A
    Diabetes Care; 2017 Jan; 40(1):117-124. PubMed ID: 27797930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
    Flint A; Kapitza C; Hindsberger C; Zdravkovic M
    Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
    Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.